Sign in

CIK 0001104506

  • Large accelerated filer
Ticker
INSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
VA
Entity type
Operating
EIN
541972729
Phone
+1 908-977-9900
Business address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
  1. 4 Grant or award Chief People Strategy Officer acquired 5,578 shares (grant or award)
  2. 4 Grant or award Chair and CEO acquired 22,314 shares (grant or award)
  3. 4 Planned sale Chief Medical Officer sold 11,724 shares at an average $65.79 ($771,276)
  4. 4 Grant or award Chief Legal Officer acquired 5,578 shares (grant or award)
  5. 4 Grant or award Director acquired 5,058 shares (grant or award)
  6. 4 Grant or award Director acquired 5,058 shares (grant or award)
  7. 4 Grant or award Director acquired 5,058 shares (grant or award)
  8. 4 Grant or award Director acquired 5,058 shares (grant or award)
  9. 4 Grant or award Director acquired 5,058 shares (grant or award)
  10. 4 Grant or award Director acquired 5,058 shares (grant or award)
  11. 4 Grant or award Director acquired 5,058 shares (grant or award)
  12. 4 Open-market sale Chief Legal Officer sold 4,816 shares at an average $67.62 ($325,673)
  13. 4 Open-market sale Chief People Strategy Officer sold 6,235 shares at an average $67.37 ($420,076)
  14. 4 Open-market sale Chair and CEO sold 21,213 shares at an average $66.73 ($1,415,573)
  15. 4 Open-market sale Chief Medical Officer sold 10,152 shares at an average $67.43 ($684,570)
  16. 4 Open-market sale Chief Financial Officer sold 10,504 shares at an average $67.47 ($708,681)
  17. 4 Open-market sale Chief Operating Officer sold 9,407 shares at an average $67.36 ($633,654)
  18. 4 Gift Director gave 576 shares (gift)
  19. 4 Planned sale Chair and CEO sold 6,830 shares at an average $72.57 ($495,668)
  20. 4 Planned sale Chair and CEO sold 6,830 shares at an average $70.16 ($479,177)

Page 7 of 40 · 788 filings